Blaise
Blaise Barrelet, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090083421 | Internet Website Traffic Flow Analysis - An Internet-based analysis tool follows, in real-time, the flow of traffic through a website. For every website page requested by a website visitor, the state of the visitor's browser is recorded and data relating to the path visitors take through the website is collected and studied. The state of the visitor's browser path is maintained in a traffic analysis cookie that is passed between a website file server and the visitor browser with every page requested for viewing. The cookie is maintained in a size that can be passed from server to browser and back again without negatively impacting server performance and without negatively impacting browser performance. The data in the cookie can follow the visitor browser through independent file servers, regardless of how the pages of a website might be distributed in storage. | 03-26-2009 |
Blaise Bossy, Carlsbad, CA US
Patent application number | Description | Published |
---|---|---|
20090279769 | METHOD FOR DETECTING RARE EVENT - Provided are methods, compositions and kits for efficiently and accurately identifying rare events in a biological sample. | 11-12-2009 |
Blaise Corthesy, Cugy CH
Patent application number | Description | Published |
---|---|---|
20120100167 | ALLERGEN PEPTIDE FRAGMENTS AND USE THEREOF FOR TREATMENT OF DUST MITE ALLERGIES - The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen. | 04-26-2012 |
20140193444 | ALLERGEN PEPTIDE FRAGMENTS AND USE THEREOF FOR TREATMENT OF DUST MITE ALLERGIES - The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen. | 07-10-2014 |
20160095899 | Allergen Peptide Fragments and Use Thereof for Treatment of Birch Pollen Allergies - The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen. | 04-07-2016 |
Blaise Corthesy, Lausanne CH
Patent application number | Description | Published |
---|---|---|
20110268743 | PROBIOTICS, SECRETORY IgA AND INFLAMMATION - The present invention relates generally to the field of nutrition, health and wellness. In particular the present invention relates to probiotics and ways to increase their effectiveness. One embodiment of the present invention relates to a combination of probiotics with SIgA and possible uses of this combination. For example a use of a composition comprising SIgA and at least one probiotic for the preparation of a product to treat or prevent inflammation is disclosed. | 11-03-2011 |
20120014963 | PROBIOTICS, SECRETORY IGA AND INFECTION - The present invention relates generally to the field of nutrition, health and wellness. In particular the present invention relates to probiotics and ways to increase their effectiveness. One embodiment of the present invention relates to a combination of probiotics with secretory IgA and possible uses of this combination. For example a use of a composition comprising secretory IgA and at least one probiotic for the preparation of a product to treat or prevent infection is disclosed. | 01-19-2012 |
20160106834 | PROBIOTICS, SECRETORY IgA AND INFECTION - Ways to increase the effectiveness of probiotics is disclosed. One embodiment relates to a combination of probiotics with secretory IgA and possible uses of this combination. For example, a method of using a composition comprising secretory IgA and at least one probiotic to prepare a product to treat or prevent infection is disclosed. | 04-21-2016 |
Blaise Corthésy, Thierrens CH
Patent application number | Description | Published |
---|---|---|
20140371431 | PROCESS FOR PREPARATION OF SECRETORY IgA AND SECRETORY IgM - A process for synthesizing and separating secretory IgA from a mixture of IgA monomer and IgA dimer is provided. The process includes covalently binding affinity tagged or epitope tagged recombinant secretory component to the IgA dimer in the mixture and binding the affinity tagged or an epitope tagged secretory IgA to immobilized moieties on the solid phase support resin to which the affinity tag or epitope tag binds and then eluting the affinity tagged or an epitope tagged secretory IgA with release buffer. A process for synthesizing and separating secretory IgM from a mixture of IgM and other plasma proteins is also provided. The process includes covalently binding affinity tagged or an epitope tagged recombinant secretory component to the IgM in the mixture and binding the affinity tagged or an epitope tagged secretory IgM to immobilized moieties on the solid phase support resin and then eluting the peptide tagged secretory IgM with a release buffer. | 12-18-2014 |
20150056180 | COMPOSITIONS COMPRISING SECRETORY - LIKE IMUNOGLOBULINS - The invention relates to methods for preparing compositions comprising secretory-like immunoglobulin, in particular secretory-like IgA and/or secretory-like IgM, and compositions obtainable by the methods. | 02-26-2015 |
Blaise Didonato, Jr., Waterford, MI US
Patent application number | Description | Published |
---|---|---|
20160138525 | EGR DEVICE IN INTAKE MANIFOLD - A housing has an outer pipe, an inner pipe, and an EGR inlet. The inner pipe is located inside the outer pipe. The inner pipe defines an inner passage internally. The inner pipe defines an annular passage externally with the outer pipe. The EGR inlet defines an EGR channel therein to communicate with the annular passage. The inner pipe has an end surface defining a throttle passage extending circumferentially. The throttle passage communicates the annular passage with the inner passage radially inward. The throttle passage is narrow on a side of the EGR channel and is wide on an opposite side of the EGR channel. | 05-19-2016 |
Blaise Doughan, Nepean CA
Patent application number | Description | Published |
---|---|---|
20130086134 | SYSTEMS AND METHODS FOR OBJECT TO XML MAPPINGS - Systems and methods are provided for automatically provisioning resources based on application characteristics. In accordance with an embodiment, a system can include a computer, including a computer readable medium and processor. The system can further include one or more servers executing on the computer and an extensible application deployed to the one or more servers, wherein the application includes a plurality of real properties. A plurality of tenants can each utilize the application at the one or more servers. The extensible application is configured to be customized for each tenant, wherein customizing includes for each tenant, defining one or more virtual properties for the application in a metadata file, and mapping the one or more virtual properties to the application using the metadata file. | 04-04-2013 |
Blaise Fracheboud, Plan-Les-Ouates CH
Patent application number | Description | Published |
---|---|---|
20140293757 | DEVICE FOR DISPLAYING TIME INFORMATION | 10-02-2014 |
20140355396 | SPRING FOR CLOCK MOVEMENT | 12-04-2014 |
20140362670 | SPRING FOR CLOCK MOVEMENT | 12-11-2014 |
Blaise Friery, Pleasant Prairie, WI US
Patent application number | Description | Published |
---|---|---|
20150275773 | ELECTRIC HYBRID POWERTRAIN REGENERATION EFFICIENCY IMPROVEMENT - A method and system for increasing regenerative energy available during deceleration by reducing engine pumping losses. The method includes a controller that reduces fuel delivery to the engine and closes an engine throttle during deceleration. The controller identifies the maximum kinetic energy available during deceleration and opens an exhaust gas recirculation (EGR) valve and engine throttle as necessary to reduce a vacuum in an engine intake manifold, thus minimizing engine pumping losses and increasing regenerative energy available during deceleration while ensuring that a catalyst temperature is above a catalyst temperature threshold. | 10-01-2015 |
Blaise Ganzel, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20090077963 | Slip Control Boost Braking System - A master cylinder includes a housing and a first secondary piston disposed in the housing. The first secondary piston cooperates with the housing to define a first secondary chamber which changes volume as the first secondary piston moves in the housing. A second secondary piston is disposed in the housing and cooperates with the housing to define a second secondary chamber which changes volume as the second secondary piston moves in the housing. A stepped primary piston is disposed in the housing. The primary piston cooperates with the housing to define a primary chamber which changes volume as the primary piston moves in the housing. The primary piston defines an abutment surface which can be driven into abutment with the first secondary piston and the second secondary piston to move the first secondary piston and the second secondary piston. A primary piston spring maintains a restorative force on the primary piston when actuated. | 03-26-2009 |
20110185723 | HYDRAULIC BRAKE SYSTEM WITH CONTROLLED BOOST - A vehicle brake system includes a brake pedal unit coupled to a vehicle brake pedal. The system includes an input piston connected to operate a pedal simulator during a normal braking mode, and coupled to actuate a pair of output pistons during a manual push through mode. The output pistons are operable to generate brake actuating pressure at first and second outputs of the brake pedal unit. A hydraulic pressure source supplies fluid at a controlled boost pressure. A hydraulic control unit is adapted to be hydraulically connected to the brake pedal unit and the hydraulic pressure source. The hydraulic control unit includes a slip control valve arrangement, and a switching base brake valve arrangement for switching the brake system between the normal braking mode wherein boost pressure from the pressure source is supplied to first and second vehicle brakes, and the manual push through mode wherein brake actuating pressure from the brake pedal unit is supplied to the first and second vehicle brakes. The input piston cooperates with a seal mounted in the brake pedal unit to provide for a progressive rate of friction therebetween as the input piston is advanced in the brake pedal unit by the brake pedal. | 08-04-2011 |
20120133201 | Attenuator For A Vehicle Braking System - A vehicle braking system includes a slip control system operable in an electronic stability control (ESC) mode to automatically and selectively apply the brakes in an attempt to stabilize the vehicle when an instability condition has been sensed. The slip control system is further operable in an adaptive cruise control (ACC) mode to automatically apply the brakes to slow the vehicle in response to a control signal. The slip control system includes a variable speed motor drive piston pump for supplying pressurized fluid pressure to the brakes through a valve arrangement. In the ESC mode, the pump motor operates in an ESC speed range, and in the ACC mode, the pump motor operates in an ACC speed range lower than the ESC speed range. The slip control system further includes an attenuator connected to a pump outlet for dampening pump output pressure pulses prior to application to the brakes. The attenuator includes an elastomeric member located in an attenuator chamber of a housing. The attenuator chamber defines a shoulder and the elastomeric member includes a flange which rests on the shoulder and locates the elastomeric member in a predetermined axial position within the attenuator chamber. An outside wall of the elastomeric member includes circumferentially extending grooves defining ribs between adjacent grooves. | 05-31-2012 |
Blaise Luzolo, Rochester, NY US
Patent application number | Description | Published |
---|---|---|
20140272697 | TONER COMPOSITION HAVING IMPROVED CHARGE CHARACTERISTICS AND ADDITIVE ATTACHMENT - A method of making a toner composition includes preparing raw toner particles, increasing a surface area of the raw toner particles by contacting the raw toner particles with a base to produce base-treated raw toner particles, and mixing the base-treated raw toner particles with at least one surface additive such that the at least one surface additive attaches to a surface of the base-treated raw toner particles to obtain blended toner particles. A toner composition includes blended toner particles containing base-treated raw toner particles, and at least one surface additive attached to a surface of the base-treated raw toner particles, wherein a ratio of a triboelectric charge of the blended toner composition to a triboelectric charge of the base-treated raw toner particles is from about 0.8 to about 1.2. | 09-18-2014 |
Blaise Mibeck, Grand Forks, ND US
Patent application number | Description | Published |
---|---|---|
20090285734 | CATALYST FOR GENERATING OXIDIZED MERCURY FOR TESTING MERCURY CONTINUOUS EMISSION MONITORS (CEM) - The present invention discloses a catalyst, system, and process for oxidizing mercury. The catalyst can include a substrate and a layer attached to at least part of the substrate. The layer contains a noble metal and has an average thickness of less than 100 nanometers. The substrate can be a plurality of glass fibers that provides for a relatively high surface area for the layer to be attached to. In the alternative, the substrate can be a porous substrate that provides for a high surface area for the layer to be attached to. | 11-19-2009 |
Blaise N'Zemba, Brampton CA
Patent application number | Description | Published |
---|---|---|
20100016243 | CRYSTALLINE D-ISOGLUTAMYL-D-TRYPTOPHAN AND THE MONO AMMONIUM SALT OF D-ISOGLUTAMYL-D-TRYPTOPHAN - A process for making pure crystalline D-isoglutamyl-D-tryptophan is provided which includes the step of deprotecting essentially pure N-tert-butoxycarbonyl-D-isoglutamyl-D-tryptophan or its diester to yield essentially pure D-isoglutamyl-D-tryptophan. A process is also provided for the preparation of pure mono ammonium salt of D-isoglutamyl-D-tryptophan from essentially pure N-tert-butoxycarbonyl-D-isoglutamyl-D-tryptophan. D-isoglutamyl-D-tryptophan, ammonium salt (1:1) is a stable pharmaceutical solid. | 01-21-2010 |
20100029742 | CRYSTALLINE FORMS OF THE MONO-SODIUM SALT OF D-ISOGLUTAMYL-D-TRYPTOPHAN - The present invention relates to crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan, pharmaceutical compositions comprising them, their use in the treatment of various diseases and conditions, and processes for their preparation. In particular, the present invention relates the crystal modification 1 (polymorphic form F), the crystal modification 2 (polymorphic form I), and the crystal modification 3 (polymorphic form X) of the mono-sodium salt of D-isoglutamyl-D-tryptophan. | 02-04-2010 |
20100056803 | Pharmaceutically Acceptable Salts of Thymodepressin and Processes for their Manufacture - The present invention relates to pharmaceutically acceptable crystalline and amorphous salts of D-isoglutamyl-D-tryptophan as well as processes for their manufacture, pharmaceutical compositions comprising them, and their uses in the preparation of pharmaceutical compositions for the treatment of various conditions and/or diseases. In particular, the present invention relates to D-isoglutamyl-D-tryptophan potassium salt (1:1), D-isoglutamyl-D-tryptophan lithium salt (1:1), D-isoglutamyl-D-tryptophan calcium salt (2:1), D-isoglutamyl-D-tryptophan magnesium salt (2:1), and D-isoglutamyl-D- tryptophan organic ammonium salts (1:1). | 03-04-2010 |
20120270882 | FLUORINATED DERIVATES OF 3-HYDROXYPYRIDIN-4-ONES - Provided are compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Frederich's Ataxia. | 10-25-2012 |
20130005987 | CRYSTALLINE FORMS OF THE MONO-SODIUM SALT OF D-ISOGLUTAMYL-D-TRYPTOPHAN - The present invention relates to crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan, pharmaceutical compositions comprising them, their use in the treatment of various diseases and conditions, and processes for their preparation. In particular, the present invention relates the crystal modification 1 (polymorphic form F) of the mono-sodium salt of D-isoglutamyl-D-tryptophan. | 01-03-2013 |
20130045929 | CRYSTALLINE FORMS OF THE MONO-SODIUM SALT OF D-ISOGLUTAMYL-D-TRYPTOPHAN - The present invention relates to crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan, pharmaceutical compositions comprising them, their use in the treatment of various diseases and conditions, and processes for their preparation. In particular, the present invention relates the crystal modification 1 (polymorphic form F) of the mono-sodium salt of D-isoglutamyl-D-tryptophan. | 02-21-2013 |
20130045930 | CRYSTALLINE FORMS OF THE MONO-SODIUM SALT OF D-ISOGLUTAMYL-D-TRYPTOPHAN - The present invention relates to crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan, pharmaceutical compositions comprising them, their use in the treatment of various diseases and conditions, and processes for their preparation. In particular, the present invention relates the crystal modification 2 (polymorphic form I) of the mono-sodium salt of D-isoglutamyl-D-tryptophan. | 02-21-2013 |
20130059791 | CRYSTALLINE D-ISOGLUTAMYL-D-TRYPTOPHAN AND THE MONO AMMONIUM SLAT OF D-ISOGLUTAMYL-D-TRYPTOPHAN - A process for making pure crystalline D-isoglutamyl-D-tryptophan is provided which includes the step of deprotecting essentially pure N-tert-butoxycarbonyl-D-isoglutamyl-D-tryptophan or its diester to yield essentially pure D-isoglutamyl-D-tryptophan. A process is also provided for the preparation of pure mono ammonium salt of D-isoglutamyl-D-tryptophan from essentially pure N-tert-butoxycarbonyl-D-isoglutamyl-D-tryptophan. D-isoglutamyl-D-tryptophan, ammonium salt (1:1) is a stable pharmaceutical solid. | 03-07-2013 |
20130060048 | CRYSTALLINE D-ISOGLUTAMYL-D-TRYPTOPHAN AND THE MONO AMMONIUM SLAT OF D-ISOGLUTAMYL-D-TRYPTOPHAN - A process for making pure crystalline D-isoglutamyl-D-tryptophan is provided which includes the step of deprotecting essentially pure N-tert-butoxycarbonyl-D-isoglutamyl-D-tryptophan or its diester to yield essentially pure D-isoglutamyl-D-tryptophan. A process is also provided for the preparation of pure mono ammonium salt of D-isoglutamyl-D-tryptophan from essentially pure N-tert-butoxycarbonyl-D-isoglutamyl-D-tryptophan. D-isoglutamyl-D-tryptophan, ammonium salt ( | 03-07-2013 |
20130072692 | PHARMACEUTICALLY ACCEPTABLE SALTS OF THYMODEPRESSIN AND PREOCESSES FOR THEIR MANUFACTURE. - The present invention relates to pharmaceutically acceptable crystalline and amorphous salts of D-isoglutamyl-D-tryptophan as well as processes for their manufacture, pharmaceutical compositions comprising them, and their uses in the preparation of pharmaceutical compositions for the treatment of various conditions and/or diseases. In particular, the present invention relates to D-isoglutamyl-D-tryptophan potassium salt (1:1), D-isoglutamyl-D-tryptophan lithium salt (1:1), D-isoglutamyl-D-tryptophan calcium salt (2:1), D-isoglutamyl-D-tryptophan magnesium salt (2:1), and D-isoglutamyl-D-tryptophan organic ammonium salts (1:1). | 03-21-2013 |
20150225341 | PHARMACEUTICALLY ACCEPTABLE SALTS OF THYMODEPRESSIN AND PROCESSES FOR THEIR MANUFACTURE - The present invention relates to pharmaceutically acceptable crystalline and amorphous salts of D-isoglutamyl-D-tryptophan as well as processes for their manufacture, pharmaceutical compositions comprising them, and their uses in the preparation of pharmaceutical compositions for the treatment of various conditions and/or diseases. In particular, the present invention relates to D-isoglutamyl-D-tryptophan amorphous potassium salt. | 08-13-2015 |
20150274665 | FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES - Provided are compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Frederich's Ataxia. | 10-01-2015 |
20150335626 | FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES - Provided are compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Frederich's Ataxia. | 11-26-2015 |
20160083346 | Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones - Compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Friedreich's ataxia. | 03-24-2016 |
Blaise Paratte, Colombier CH
Patent application number | Description | Published |
---|---|---|
20100096451 | Key-Card Access System for Providing Selective Access to Medical Equipment - An access system for controlling access of a user to one of several unique operative modes of an electronic device used to communicate with an implantable medical device. The access system includes a portable keycard, which is held by a user. The keycard has embedded magnets arranged in a unique predetermined pattern. The electronic device has a housing that provides a slot and a channel for receiving the keycard by the user. A sensing circuit and a processing circuit are both provided. The sensing circuit includes Hall-effect transducers positioned next to the channel so that upon inserted of the keycard, certain ones of these Hall-effect transducers will reside adjacent a magnet, depending on the particular unique pattern. A magnet positioned adjacent a Hall-effect transducer will cause the transducer to send an output signal to the processor indicating the presence of a magnet at the location of the Hall-effect transducer. The Hall-effect transducers collectively generate an electronic pattern representing the particular identity of the keycard. The processor compares this electronic pattern with one of several stored in electronic memory and provides selective access to the device in response to successfully identifying a match. A doctor, a technician, a salesperson and a factory assembly worker are examples of users of this system and each will be granted predetermined access rights to operate the device. Additional Hall-effect transducers may be provided to help detect the intrusion of magnetic fields produced from magnets not located with the keycard. The process will deny any access to the device should any such remove magnetic fields be detected. | 04-22-2010 |
Blaise Rithener, La Tour-De-Peilz CH
Patent application number | Description | Published |
---|---|---|
20110011271 | BEVERAGE PRODUCTION DEVICE FOR PRODUCING A BEVERAGE FROM A SINGLE-USE CAPSULE - Beverage production device for producing a beverage from a single-use capsule containing a beverage ingredient, comprising: a brewing unit ( | 01-20-2011 |
20120266755 | CARTRIDGE EXTRACTION DEVICE | 10-25-2012 |
20120298258 | BEVERAGE PREPARATION MACHINE FOR LARGE SIZE BEVERAGES - A beverage preparation machine ( | 11-29-2012 |
20120305111 | BEVERAGE DISPENSER WITH SAFE CLEANING ARRANGEMENT - A beverage preparation machine ( | 12-06-2012 |
20120305597 | BEVERAGE DISPENSER WITH HYGIENIC CLEANING CYCLE - A flavoured-beverage preparation machine ( | 12-06-2012 |
20130112318 | SECURE CUP SUPPORT FOR BEVERAGE MACHINE - A machine ( | 05-09-2013 |
20130118359 | ADVANCED HEATING DEVICE - A beverage preparation machine comprises: a heater ( | 05-16-2013 |
20130276636 | MODULAR BEVERAGE DISPENSING SYSTEM - A beverage preparation system ( | 10-24-2013 |
20140178546 | CARTRIDGE CHAMBER OF EXTRACTION SYSTEM - A system comprises a cartridge ( | 06-26-2014 |
20140212556 | CARTRIDGE POSITIONING SYSTEM | 07-31-2014 |
20140255573 | CARTRIDGE REMOVAL SYSTEM | 09-11-2014 |
20140326361 | LONG-LASTING CARTRIDGE PIERCER | 11-06-2014 |
20140356500 | CARTRIDGE EXTRACTION DEVICE | 12-04-2014 |
Blaise Rithener, La Tour-De-Peilu CH
Patent application number | Description | Published |
---|---|---|
20120199007 | CARTRIDGE EXTRACTION DEVICE | 08-09-2012 |
20130047863 | ERGONOMIC CAPSULE EXTRACTION DEVICE | 02-28-2013 |
Blaise Sanouillet, Rickmansworth GB
Patent application number | Description | Published |
---|---|---|
20130246707 | TWO STAGE CHECKSUMMED RAID STORAGE MODEL - A method for writing a logical data block to storage. The method includes receiving a request to write a logical data block to a storage pool, allocating a number of physical log blocks in a RAID log and a parity block for the logical data block, and writing the logical data block and the parity block to the physical log blocks. The number of the physical log blocks are less than a number of disks storing the RAID log. The method further includes allocating space in a physical slab block in a RAID slab for the logical data block, copying data including the logical data block to the space in the physical slab block, and updating, in the RAID slab, a check-sum corresponding to the physical slab block and a parity block that includes the data stripe having the physical slab block based on the data copied. | 09-19-2013 |
20150355968 | SYSTEMS AND METHODS FOR SEQUENTIAL RESILVERING - Implementations claimed and described herein provide systems and methods for the efficient rebuilding of a failed storage device through sequential resilvering. In one implementation, blocks for resilvering are discovered. The blocks correspond to input/output requests not successfully completed for a failed storage device. A coarse grained sorting of the blocks is performed based on a block location of each of the blocks on the failed storage device. The block locations of the blocks are stored in memory according to the coarse grained sorting. A fine grained sorting of the blocks is performed based on the coarse grained sorting of the blocks. The blocks are sequentially resilvered based on the fine grained sorting. | 12-10-2015 |
Blaise Vignon US
Patent application number | Description | Published |
---|---|---|
20090122083 | Edge evaluation techniques for graphics hardware - The edge evaluation technique, in accordance with one embodiment of the present technology, includes determining a number of edges of a given primitive to be evaluated. The technique also includes sequencing evaluation of a first edge by a first edge evaluation circuit and a second edge by a second edge evaluation circuit during a first clock cycle. The technique further includes sequencing evaluation of a third edge by the first edge evaluation circuit and a fourth edge by the second edge evaluation circuit during a second clock cycle if three or more edges are to be evaluated. | 05-14-2009 |
Blaise Wooderson, Olathe, KS US
Patent application number | Description | Published |
---|---|---|
20140013958 | HYBRID COFFEE MAKER WITH MULTIPLE BREWING MODES - A drink brewer is operable to hold brewable grounds in either an open filter or an enclosed capsule and brew a drink using the grounds. The drink brewer includes a water dispensing station and a brew basket structure. The water dispensing station includes a water nozzle to dispense water onto the grounds. The brew basket structure presents a brew chamber. The brew basket structure is shiftable between an open filter brewing configuration and a capsule brewing configuration. | 01-16-2014 |
20140106037 | FOODSTUFF TREAT MAKER WITH FORMING PLATES - A foodstuff treat maker operable to shape a foodstuff material into a shaped foodstuff treat. The foodstuff treat maker includes a pair of opposed forming plates shiftably attached relative to one another and presenting respective forming surfaces. One of the forming surfaces defines a protrusion and the other forming surface defines a cavity. The protrusion is at least partly received in the cavity in a forming position so that the pair of forming plates are mated with one another, with the mated forming surfaces cooperatively shaping foodstuff material applied thereto. | 04-17-2014 |
Blaise Yvert, Carignan De Bordeaux FR
Patent application number | Description | Published |
---|---|---|
20110208029 | DEVICE FOR STIMULATING LIVING TISSUE BY MICROELECTRODES AND REMOVABLE MODULE AND USE THEREOF - The disclosure relates to a device for stimulating living tissue, comprising an array of stimulating microelectrodes that are placed in a defined configuration side by side and able to be selected by applying an electrical signal for stimulation by one of the microelectrodes. According to the disclosure, an additional conducting surface for application against the living tissue, is provided in the vicinity of a defined plurality of sections for local application of microelectrodes, connecting means being provided for electrical connection between the zones, and the additional conducting surface being also connected to a lead and being formed so as to ensure local stimulation via a microelectrode. | 08-25-2011 |
20130096660 | IMPLANT HAVING THREE-DIMENSIONAL SHAPE FOR ELECTRICALLY STIMULATING A NERVE STRUCTURE - The invention relates to an implant which includes, in order to electrically stimulate a nerve structure, in particular the retina, an electrically insulating substrate ( | 04-18-2013 |